Juno, WuXi JV gets a $90M round as Chi­na’s CAR-T pi­o­neers fly high with fresh cash

Close to two years af­ter Hans Bish­op at Juno and Ge Li at WuXi AppTec joined hands on a joint ven­ture to cre­ate a CAR-T com­pa­ny in Chi­na, the biotech has round­ed up a whop­ping $90 mil­lion round from a syn­di­cate that in­cludes some ma­jor Asian in­vestors in the field.

The com­pa­ny is JW Ther­a­peu­tics, bor­row­ing ini­tials from each and based in WuXi’s back yard in Shang­hai. It’s a mar­riage of Juno’s hard-won CAR-T de­vel­op­ment ex­pe­ri­ence and WuXi’s pow­er­house man­u­fac­tur­ing ca­pa­bil­i­ties. Now owned by Cel­gene, Juno is go­ing back to chip in fresh cash on this round, along with WuXi, Sin­ga­pore’s Temasek, Se­quoia Cap­i­tal Chi­na, and Yuan­Ming Cap­i­tal. Their group al­so in­cludes Oriza Seed Cap­i­tal, Yipu Cap­i­tal, AVICT Glob­al Hold­ings.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER